🚀 VC round data is live in beta, check it out!
IKS Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for IKS Health and similar public comparables like Topchoice Medical, LifeStance Health, Acadia Healthcare, Krishna Institute and more.
IKS Health Overview
About IKS Health
Inventurus Knowledge Solutions Ltd is a technology enabled healthcare solutions provider, serving the U.S healthcare market. The group offer a comprehensive care enablement platform that supports healthcare enterprises across outpatient and inpatient care settings. It is operates in in Care Enablement, empowering healthcare organizations to deliver high-quality care efficiently and sustainably through an integrated platform that combines technology and deep human expertise. The Company operates in one reportable segment which is Healthcare. Its solutions are Revenue Cycle Management, Clinical Support, and Value-Based Care.
Founded
2006
HQ
Employees
7.5K
Website
Sectors
Financials (LTM)
EV
$3B
IKS Health Financials
IKS Health reported last 12-month revenue of $351M and EBITDA of $116M.
In the same LTM period, IKS Health generated $215M in gross profit, $116M in EBITDA, and $77M in net income.
Revenue (LTM)
IKS Health P&L
In the most recent fiscal year, IKS Health reported revenue of $311M and EBITDA of $90M.
IKS Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $351M | XXX | $311M | XXX | XXX | XXX |
| Gross Profit | $215M | XXX | $123M | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 40% | XXX | XXX | XXX |
| EBITDA | $116M | XXX | $90M | XXX | XXX | XXX |
| EBITDA Margin | 33% | XXX | 29% | XXX | XXX | XXX |
| EBIT Margin | 30% | XXX | 25% | XXX | XXX | XXX |
| Net Profit | $77M | XXX | $57M | XXX | XXX | XXX |
| Net Margin | 22% | XXX | 18% | XXX | XXX | XXX |
| Net Debt | — | — | $62M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
IKS Health Stock Performance
IKS Health has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
IKS Health's stock price is $16.11.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | -1.2% | XXX | XXX | XXX | $0.34 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIKS Health Valuation Multiples
IKS Health trades at 7.8x EV/Revenue multiple, and 23.7x EV/EBITDA.
EV / Revenue (LTM)
IKS Health Financial Valuation Multiples
As of April 19, 2026, IKS Health has market cap of $3B and EV of $3B.
Equity research analysts estimate IKS Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
IKS Health has a P/E ratio of 34.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 7.8x | XXX | 8.8x | XXX | XXX | XXX |
| EV/EBITDA | 23.7x | XXX | 30.6x | XXX | XXX | XXX |
| EV/EBIT | 26.4x | XXX | 35.8x | XXX | XXX | XXX |
| EV/Gross Profit | 12.8x | XXX | 22.3x | XXX | XXX | XXX |
| P/E | 34.9x | XXX | 47.5x | XXX | XXX | XXX |
| EV/FCF | 34.1x | XXX | 92.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified IKS Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
IKS Health Margins & Growth Rates
IKS Health's revenue in the last 12 month grew by 18%.
IKS Health's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
IKS Health's rule of 40 is 52% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
IKS Health's rule of X is 80% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
IKS Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 18% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 33% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | 20% | XXX | 28% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 52% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 80% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 17% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
IKS Health Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| IKS Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Topchoice Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| LifeStance Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Acadia Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Krishna Institute | XXX | XXX | XXX | XXX | XXX | XXX |
| Concentra Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
IKS Health M&A Activity
IKS Health acquired XXX companies to date.
Last acquisition by IKS Health was on XXXXXXXX, XXXXX. IKS Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by IKS Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialIKS Health Investment Activity
IKS Health invested in XXX companies to date.
IKS Health made its latest investment on XXXXXXXX, XXXXX. IKS Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by IKS Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout IKS Health
| When was IKS Health founded? | IKS Health was founded in 2006. |
| Where is IKS Health headquartered? | IKS Health is headquartered in India. |
| How many employees does IKS Health have? | As of today, IKS Health has over 7K employees. |
| Is IKS Health publicly listed? | Yes, IKS Health is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of IKS Health? | IKS Health trades under IKS ticker. |
| When did IKS Health go public? | IKS Health went public in 2024. |
| Who are competitors of IKS Health? | IKS Health main competitors are Topchoice Medical, LifeStance Health, Acadia Healthcare, Krishna Institute. |
| What is the current market cap of IKS Health? | IKS Health's current market cap is $3B. |
| What is the current revenue of IKS Health? | IKS Health's last 12 months revenue is $351M. |
| What is the current revenue growth of IKS Health? | IKS Health revenue growth (NTM/LTM) is 18%. |
| What is the current EV/Revenue multiple of IKS Health? | Current revenue multiple of IKS Health is 7.8x. |
| Is IKS Health profitable? | Yes, IKS Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of IKS Health? | IKS Health's last 12 months EBITDA is $116M. |
| What is IKS Health's EBITDA margin? | IKS Health's last 12 months EBITDA margin is 33%. |
| What is the current EV/EBITDA multiple of IKS Health? | Current EBITDA multiple of IKS Health is 23.7x. |
| What is the current FCF of IKS Health? | IKS Health's last 12 months FCF is $81M. |
| What is IKS Health's FCF margin? | IKS Health's last 12 months FCF margin is 23%. |
| What is the current EV/FCF multiple of IKS Health? | Current FCF multiple of IKS Health is 34.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.